Back
United Therapeutics Corp. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
45
UTHR
United Therapeutics Corp.
Last Price:
$467.32
Seasonality Move:
-2.82%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 470.15 | Sell |
| 20-day SMA: | 480.92 | Sell |
| 50-day SMA: | 486.26 | Sell |
| 200-day SMA: | 380.65 | Buy |
| 8-day EMA: | 103.84 | Buy |
| 20-day EMA: | 44.5 | Buy |
| 50-day EMA: | 18.33 | Buy |
| 200-day EMA: | 4.65 | Buy |
United Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 37.28 | Buy |
| Relative Strength Index (14 RSI): | 40.24 | Sell |
| Chaikin Money Flow: | -189338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
United Therapeutics Corp. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Corp. Stock
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 467.30 while UTHR 8-day simple moving average is 470.15, which is a Sell signal.
-
The stock price of UTHR is 467.30 while United Therapeutics Corp. 20-day SMA is 480.92, which makes it a Sell.
-
United Therapeutics Corp. 50-day simple moving average is 486.26 while UTHR share price is 467.30, making it a Sell technically.
-
UTHR stock price is 467.30 and United Therapeutics Corp. 200-day simple moving average is 380.65, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
45
United Therapeutics Corp. (UTHR)
is a Sell
Is United Therapeutics Corp. a Buy or a Sell?
-
United Therapeutics Corp. stock is rated a SellThe current United Therapeutics Corp. [UTHR] share price is $467.30. The Score for UTHR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Corp. Stock Info
Market Cap:
20.1B
Price in USD:
467.30
Share Volume:
274.2K
United Therapeutics Corp. 52-Week Range
52-Week High:
519.99
52-Week Low:
266.98
Sell
45
United Therapeutics Corp. (UTHR)
is a Sell
United Therapeutics Corp. Share Price Forecast
-
What is the United Therapeutics Corp. stock price today?The United Therapeutics Corp. stock price is 467.30 USD today.
-
Will UTHR stock go up or go down?United Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics Corp. is overvalued.
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 467.30 while UTHR 8-day exponential moving average is 103.84, which is a Buy signal.
-
The stock price of UTHR is 467.30 while United Therapeutics Corp. 20-day EMA is 44.50, which makes it a Buy.
-
United Therapeutics Corp. 50-day exponential moving average is 18.33 while UTHR share price is 467.30, making it a Buy technically.
-
UTHR stock price is 467.30 and United Therapeutics Corp. 200-day simple moving average is 4.65, creating a Buy signal.
Fundamental Analysis of United Therapeutics Corp.
Is United Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $1.56 per share.
Technical Analysis of United Therapeutics Corp.
Should I short United Therapeutics Corp. stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 37.28, suggesting United Therapeutics Corp. is a Buy
-
United Therapeutics Corp. Relative Strength Index (RSI) is 40.24, which suggest United Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for United Therapeutics Corp. is ( - ), which suggest United Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for United Therapeutics Corp. is ( - ), which suggest United Therapeutics Corp. is a Buy
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.